Winslow Capital Management
TECH icon

Winslow Capital Management’s Bio-Techne TECH Stock Holding History

Winslow Capital Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-3,147,924
Closed -$261M – 62
2022
Q4 		$261M Buy
3,147,924
+384,956
+14% +$30.6M 1.45% 36
2022
Q3 		$196M Sell
2,762,968
-337,428
-11% -$29.2M 1.15% 40
2022
Q2 		$269M Buy
3,100,396
+163,536
+6% +$15.3M 1.44% 36
2022
Q1 		$318M Buy
2,936,860
+412,688
+16% +$42.6M 1.38% 30
2021
Q4 		$326M Buy
2,524,172
+1,349,360
+115% +$165M 1.21% 39
2021
Q3 		$142M Sell
1,174,812
-4,752
-0.4% -$578K 0.56% 50
2021
Q2 		$133M Sell
1,179,564
-46,664
-4% -$4.91M 0.52% 49
2021
Q1 		$117M Buy
+1,226,228
New +$112M 0.49% 51

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Winslow Capital Management's TECH Position: Q1 2023 in Review

Winslow Capital Management sold out of Bio-Techne (TECH) in Q1 2023, closing a stake of 3,147,924 shares — an estimated $261M sold.

Winslow Capital Management first reported a position in TECH in Q1 2021 and held it in 8 quarters. The position peaked at $326M in Q4 2021. 550 funds tracked by Wall St. Rank hold TECH as of Q1 2023.

  • Winslow Capital Management reported no remaining Bio-Techne position as of Q1 2023 after selling out during the quarter.
  • Winslow Capital Management sold 3,147,924 Bio-Techne shares in Q1 2023, an estimated $261M.
  • Winslow Capital Management first reported a position in Bio-Techne in Q1 2021 and held it in 8 quarters.
  • Winslow Capital Management's Bio-Techne position peaked at $326M in Q4 2021.
  • 550 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2023.

Based on Winslow Capital Management's 13F filing for Q1 2023, filed 11 May 2023.